|Author (Corporate)||European Commission|
|Series Title||Official Journal of the European Union|
|Series Details||L 31I, Pages 1-8|
|Content Type||Legislation, News|
Implementing Regulation (EU) 2021/111 - adopted by the European Commission on 30 January 2021 - putting in place a measure requiring vaccine exports to be subject to an authorisation by Member States.
The objective of this measure is to ensure timely access to COVID-19 vaccines for all EU citizens and following concerns over the lack of transparency around the ways some companies are operating when it comes to vaccine exports outside the European Union. The European Commission has argued that, considering the investment from the EU to support the rapid development and production of several vaccines, it needs to ensure companies fulfil their contractual commitments.
This Implementing Regulation is a temporary export transparency and export authorisation mechanism on the basis of Regulation 2015/479 on common rules for exports. This measure was introduced in the context of the vaccination rollout across the European Union (EU) and the announcement of delays in delivering a number of vaccine doses.
|Subject Categories||Health, Trade|
|Subject Tags||Export | Import Controls, Medicines | Medical Devices|
|International Organisations||European Union [EU]|